Menu Search
Equities

Voxel SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert
0QDB:LSE

Voxel SA

Actions
  • Price (PLN)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta0.5283
Data delayed at least 20 minutes.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Voxel SA is a Poland-based company active in the healthcare sector. It provides services in the fields of diagnostic imaging, teleradiology and outsourcing, as well as information technology (IT) systems for hospitals and diagnostic centers. As of December 31, 2011, the Company operated two subsidiaries, 95.24%-owned Alteris SA and wholly owned CDO Sp. z o.o. On November 7, 2012, the Company sold its entire stake in Centrum Diagnostyki i Terapii Onkologicznej Sp. z o.o.

  • Revenue in PLN (TTM)568.83m
  • Net income in PLN102.98m
  • Incorporated2005
  • Employees323.00
  • Location
    Voxel SAul. Wielicka 265KRAKOW 30-663PolandPOL
  • Phone+48 326060500
  • Fax+48 326060519
  • Websitehttps://voxel.pl/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		VOX:WSE since
announced		Transaction
value
Supramed Konin Sp z o oDeal completed18 Sep 202518 Sep 2025Deal completed-16.47%--
Pro-Scan Sp z o oAnnounced02 Jul 202502 Jul 2025Announced-11.80%67.00k
Data delayed at least 15 minutes, as of Feb 13 2026.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.